IT IS of the greatest importance in the management of rheumatic fever to decide whether or not active carditis is present. At times, however, this decision may be difficult. To establish the diagnosis of active carditis in a case of rheumatic fever, at least one of its five chief manifestations must be recognized, namely, mitral valvulitis, aortic valvulitis, partial heart block, pericarditis, and cardiac failure. It is doubted that there are other manifestations of rheumatic carditis. Sinus tachycardia is not disproportionate to fever, anxiety, pericardial effusion, or heart failure. Gallop rhythm in a child is difficult to distinguish from a normal third heart sound.
Technical and laboratory procedures are of little help to the clinician in this respect. Enlargement of the heart shadow rarely if ever occurs in the absence of advanced valvular disease, heart failure, or pericardial effusion. The electrocardiogram shows no obvious changes other than those of partial heart block, pericarditis, or the consequences of advanced valvular disease, and a normal tracing does not exclude active carditis. Considerable doubt has been thrown on the value of prolongation of the Q-T interval,' as found by Taran and Szilagyi2 and Abrahams.3 The Creactive protein, leukocyte count, and the erythrocyte sedimentation rate4 may provide good evidence of rheumatic activity, but they fail to identify carditis.
Hence the importance of searching for a diagnostic test of active carditis in rheumatic fever is clear. The serum glutamic oxaloacetic transaminase (SGOT) level was found to be elevated in myocardial infarction. 5 Nydick et al.6 found significant elevation of SGOT ac-tivity in 65 per cent of their cases with clinically active carditis. Lactic dehydrogenase (LDH) is an enzyme that catalyzes the interconversion of lactate and pyruvate. It has a wide tissue distribution and is particularly abundant in the myocardium, skeletal muscle, liver, and kidney. Necrosis, degeneration, or inflammation results in an increased rate of release of the enzyme from the cells and a rise of its level in the serum. Since necrotic, degenerative, and inflammatory changes are all features of the pathologic picture of rheumatic carditis, and since in myocardial infarction, the concentration of serum lactic dehydrogenase enzyme rises to high levels, 7-'4 it was decided to see whether the level of this enzyme in patients with rheumatic fever could be used for the diagnosis of active carditis, and to compare it with the behavior of SGOT.
Methods and Materials
The present study was carried out on 54 rheumatic patients divided in the following groups.
Group 1 comprised 30 patients with active rheumatic fever admitted to the Medical Unit, Cairo University Hospitals, from November 1962 to January 1964. These consisted of two subgroups: subgroup A, 13 patients with active carditis (cases 1 to 13) and subgroup B, 17 patients without evidence of active carditis (cases 14 to 30).
The diagnosis of active rheumatic fever was based on the criteria suggested by Jones,'5 and the diagnosis of active carditis was based on the presence of at least one of its five chief manifestations. 16 On admission the following investigations were carried out on all patients before treatment: full blood study and erythrocyte sedimentation rate; serum glutamic oxaloacetic transaminase activity as determined by the method of 
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All patients in both subgroups were put to bed rest. The patients with carditis were treated with prednisone, since it was thought that salicylates might be harmful,19 while patients with active rheumatic fever, but with no evidence of carditis, were treated with acetylsalicylic acid. The erythrocyte sedimentation rate and the levels of SGOT and LDH were estimated weekly during the period of treatment and careful clinical observation in the hospital, which varied from 3 to 13 weeks.
Group 2 comprised 24 patients with inactive chronic rheumatic valvular heart disease. These consisted of two subgroups of 14 patients with compensated hearts and 10 patients with heart failure. The SGOT and LDH levels were estimated only once in each of these patients.
In addition, SGOT and LDH levels were also estimated in 80 normal subjects to establish the normal levels, and in 10 patients with cardiac failure of nonrheumatic etiology, to confirm whether heart failure per se can alter the levels of SGOT and LDH.
Results
The values of SGOT and LDH in units per ml. in the 80 normal control subjects, as well as in the 14 cases of inactive, compensated, chronic rheumatic valvular heart disease, 10 cases of inactive, decompensated, chronic rheumatic valvular heart disease, and 10 cases of cardiac failure of nonrheumatic etiology are shown and statistically analyzed in table 1.
The mean serum LDH level in the normal control subjects was 297 units per ml. (standard deviation 85), and the maximum observed level 500 units, findings that are rather similar to those of Wr6blewski20 21 and Mac-Donald et al." Since the calculated upper limit-mean plus 2 standard deviations-was found to be even lower-467 units per ml.-values above 500 units were considered elevated. The mean SGOT level in the normal control subjects was 7.6 units (standard deviation 5), and the maximal normal upper limit observed was 18 units per ml. The calculated upper limit was found to be 17 units. Values above 18 units were considered elevated. Table 1 clearly demonstrates that the values of LDH and SGOT were within the normal range in cases of inactive chronic rheumatic valvular heart disease, whether compensated or decompensated, as well as in cases of cardiac failure of nonrheumatic etiology.
Comparison of the Initial Level of LDH in Cases of Rheumatic Activity with and without Carditis
A comparative statistical analysis of the initial levels of LDH in patients with rheumatic activity with or without carditis and normal control subjects is shown in table 2. These data show that the mean initial level of LDH in patients with rheumatic activity whether with or without carditis is significantly high.
All patients with active rheumatic carditis showed elevation of serum LDH in the initial blood sample in comparison with four of 17 patients without carditis, a highly significant difference (p less than 0.001). Further, the maximal level of LDH in the four patients without carditis was only 640 units per ml., while in carditis the level of LDH ranged from 700 to 1,320 units per ml.
The initial level of serum LDH is, therefore, of great help in the determination of carditis in patients with active rheumatic fever, that is, a level of serum A statistical analysis of the initial levels of SGOT is shown in table 3. Although the mean level of SGOT in patients with rheumatic activity was significant-TI Initial Serum Enzyme Levels ly higher than in normal control subjects, the difference in the presence or absence of carditis was statistically insignificant. Elevation of SGOT above the maximal normal level, two of 13 with carditis and one of 17 without carditis, was also not helpful. The SGOT level in the initial sample, therefore, failed to identify carditis in cases of active rheumatic fever.
Correlation between Elevation of Serum LDH
Level and Severity of Rheumatic Carditis. Spearman's rank correlation coefficient (R) for these data was calculated to be 0.89, and by the t-test it was found highly significant (p 0.001). Consequently, there is a significant correlation between the degree of elevation of serum LDH and the degree of carditis as estimated clinically. Correlations between the level of serum LDH and SGOT, erythocyte sedimentation rate, total leukocyte count fever, tachycardia, and duration of the illness were all found to be insignificant.
Follow-up Observations of the Patients under Treatment
Thirteen patients with carditis were treated with prednisone, while the other 17 without carditis were treated with acetylsalicylic acid. The period of treatment and clinical observation in the hospital of the 30 patients with rheumatic fever varied from 3 to 13 weeks. The behavior of LDH, SGOT, and erythrocyte sedimentation rate, and the relation of these levels to the clinical condition of the patients were studied.
Eight of the 13 cases with carditis (62 per cent), all of whom were treated with predni-sone, showed a gradual decline of the original high level of serum LDH to normal, while five (38 per cent) showed a further rise before a gradual decline to normal. Of the 17 cases of active rheumatic fever, without active carditis, under treatment with acetylsalicylic acid, six cases (35 per cent) showed no rise in the level of serum LDH all through the course of the illness, while the remaining 11 cases (65 per cent) showed a rise followed by a gradual decline to normal. The maximal level reached was always below 700 units per ml. except for one instance of a level of 900 units per ml.
Six of the 13 cases with carditis showed no rise in the level of SGOT, and seven cases showed a rise and a later gradual decline to normal. Of the 17 cases without active carditis, 10 showed no rise in SGOT, while seven cases showed a rise followed by a gradual decline to normal.
The mean maximal level of serum LDH during hospitalization in patients with carditis was significantly higher than in the absence of carditis (table 5 ). The mean maximal levels of SGOT were not significantly different in the two groups. Similarly, the LDH levels were elevated significantly more frequently in the presence of carditis, but the frequency of elevated SGOT levels was not significantly different with carditis.
The return of the serum LDH level to normal was significantly more rapid in the ab-Circulation, Volume XXXII, December 1965 sence of carditis (mean 27 days from beginning of treatment) than with carditis (mean 50 days). The return of SGOT to normal was also significantly more rapid without carditis (mean 33 days from beginning of treatment) than in carditis (mean 56 days). The course of the levels of serum LDH and SGOT were not correlated during treatment in the two groups. The maximal levels and the return to normal of the two enzymes occurred synchronously or in varying sequence.
No relation was found either between the behavior of the serum LDH or SGOT levels and the erythrocyte sedimentation rate, during the course of the illness, in the two groups with and without carditis. In both groups there was a gradual decline of the erythrocyte sedimentation rate to normal levels in 2 to 3 weeks in patients without carditis and in 2 to 9 weeks in those with carditis, irrespective of the behavior of serum LDH or SGOT. The serum LDH level remained high after the erythrocyte sedimentation rate became normal after an average interval of 18 days with carditis and 9 days without carditis. In both groups of cases no correlation was found between the behavior of the serum LDH or the SGOT levels and the course of the fever, pulse rate, arthritis, or the severity, type, or course of carditis.
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Discussion
The present study demonstrates the value of the serum LDH level as a diagnostic test for the presence of active carditis in patients with rheumatic fever.
The fact that the serum LDH level was normal in inactive chronic rheumatic valvular heart disease, whether compensated or decompensated, as well as in cases of heart failure of nonrheumatic etiology excludes the associated chronic valvular rheumatic heart disease and the cardiac decompensation per se as the cause of the rise of the serum LDH level.
The serum LDH is superior to the SGOT in the detection of active carditis.
The lack of correlation of serum LDH with that of SGOT may be because serum LDH reflects necrotic, degenerative, or inflammatory changes in the myocardium more easily than SGOT, an observation which was also reported in myocardial infarction. 9 The lack of correlation of LDH with the erythrocyte sedimentation rate, leukocytic count, fever, or pulse rate, is actually a reflection of the difference in the underlying etiology of the elevation of these measures as compared with that of LDH. The serum enzyme levels, LDH and SGOT, were the last of all these tests to return to normal. In fact no case should be claimed cured before these serum enzyme levels have returned to normal.
The elevation of serum LDH or SGOT level observed in some of the patients without carditis may be due to subclinical myocardial involvement, which should not concern the treating physician, since the course of the patients under treatment was not seen to vary from those in whom no elevation of the enzyme levels was observed. The poor correlation of the level of serum LDH with the clinical behavior and the course of the erythrocyte sedimentation rate during treatment shows that the clinical criteria as well as the erythrocyte sedimentation rate are too crude to depict fine pathologic myocardial changes, which the enzyme level more sensitively reflects.
The further rise of the serum LDH level to a maximal level followed by a decline under treatment with prednisone in patients with carditis and with acetylsalicylic acid in patients without carditis may indicate that both drugs did not control the pathologic myocardial lesions in these patients, 38.5 per cent with carditis and 64.7 per cent without carditis.
Summary and Conclusions
The levels of serum LDH and SGOT were studied in 80 normal subjects to establish the normal serum levels of these enzymes in our subjects.
The levels of LDH and SGOT were found to be normal in 24 patients with chronic inactive rheumatic valvular heart disease, whether compensated or decompensated, as well as in 10 cases of heart failure of nonrheumatic etiology.
The levels of serum LDH and SGOT were determined in 30 patients with rheumatic activity, 13 with active carditis and 17 without evidence of active cardiac involvement. Serial weekly determinations of these enzyme levels were carried out all through the period of follow-up observation of these patients until they were cured.
The serum LDH level can be used as a diagnostic test of active carditis in patients with rheumatic fever, but SGOT failed to differentiate between carditis and noncarditis in these patients. A significant correlation exists between the level of serum LDH in the initial blood sample before treatment and the severity of the rheumatic carditis as estimated clinically.
The serum enzyme levels of SGOT and LDH should be followed in patients with active rheumatic carditis. The patient may not be claimed cured until the level of these enzymes in his serum has fallen to normal, for it was shown to be the last measure of activity to return to normal. The last of the two enzymes to return to normal was at times the serum LDH and at others the SGOT level.
